Profile data is unavailable for this security.
About the company
Predilife SA is a France-based company specialized in the development of predictive tests in the medical industry. The Company operates mainly in the field of oncology. Predilife offers MammoRisk, which is a predictive breast cancer test that combines medical imaging thanks to a proprietary software, DenSeeMammo, Big Data and statistics through a scoring tool and genetic profiles via a polygenic risk score (PRS). The image is analysed in order to extract the breast density and the first breast cancer risk factor. In addition, The technology used by MammoRisk makes it possible to evaluate from a database of individuals tracked over time, the risks of an individual to develop cancer compared to the fate of his/her closest neighbors through a database of a number of American and French women.
- Revenue in EUR (TTM)317.79k
- Net income in EUR-4.22m
- Incorporated2004
- Employees19.00
- LocationPredilife SAIgr Campus Cancer 1 Batiment Maurice39 Rue Camille DesmoulinsVILLEJUIF 94805FranceFRA
- Phone+33 142114211
- Websitehttps://www.predilife.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ikonisys SA | 538.56k | -2.40m | 15.05m | 11.00 | -- | 0.8235 | -- | 27.94 | -0.2499 | -0.2499 | 0.056 | 1.75 | 0.0246 | 1.14 | 6.20 | 48,960.00 | -10.94 | -- | -12.55 | -- | 2.72 | -- | -444.76 | -- | 0.0818 | -36.79 | 0.1007 | -- | 68.94 | -- | -328.57 | -- | -- | -- |
| Acticor Biotech SA | 0.00 | -18.65m | 15.47m | 24.00 | -- | 32.93 | -- | -- | -1.68 | -1.68 | 0.00 | 0.0298 | 0.00 | -- | -- | 0.00 | -145.59 | -- | -297.22 | -- | -- | -- | -- | -- | -- | -9.32 | 0.9504 | -- | -- | -- | -25.94 | -- | -- | -- |
| Valerio Therapeutics SA | 1.80m | -20.34m | 16.70m | 19.00 | -- | 1.12 | -- | 9.28 | -0.1566 | -0.1566 | 0.0133 | 0.0961 | 0.0459 | -- | 1.07 | 94,736.84 | -51.92 | -34.19 | -67.72 | -40.59 | 70.39 | 84.11 | -1,130.22 | -586.99 | -- | -171.66 | 0.3776 | -- | 24.74 | -21.73 | -4.00 | -- | 32.39 | -- |
| Plant Advanced Technologies PAT SA | 2.34m | -849.00k | 16.76m | 56.00 | -- | 2.27 | -- | 7.16 | -0.7853 | -0.7853 | 2.15 | 6.70 | 0.1368 | 0.9869 | 2.87 | 41,767.86 | -4.91 | -3.18 | -7.20 | -4.04 | 22.83 | 98.91 | -35.87 | -27.90 | 0.8691 | -16.73 | 0.4472 | -- | 1.48 | 23.72 | 25.13 | -- | 3.57 | -- |
| SMAIO SA | 7.62m | 1.06m | 18.04m | 37.00 | 16.93 | 1.67 | 7.58 | 2.37 | 0.2038 | 0.2038 | 1.46 | 2.07 | 0.5624 | 0.1871 | 17.23 | 206,027.60 | 7.81 | -7.87 | 10.24 | -19.76 | 96.95 | 96.04 | 13.89 | -22.48 | 2.54 | 11.07 | 0.1991 | -- | 212.18 | 114.99 | -62.80 | -- | -- | -- |
| Phaxiam Therapeutics SA | 1.33m | -23.49m | 18.53m | 51.00 | -- | 0.7234 | -- | 13.97 | -5.56 | -5.56 | 0.3139 | 4.22 | 0.0273 | -- | 14.82 | 26,000.00 | -48.37 | -50.69 | -66.94 | -66.25 | -- | -- | -1,771.42 | -1,009.09 | -- | -70.21 | 0.3412 | -- | -80.05 | -21.50 | -10,201.75 | -- | -56.68 | -- |
| NicOx SA | 3.57m | -17.36m | 18.84m | 11.00 | -- | 0.4103 | -- | 5.27 | -0.3721 | -0.3721 | 0.0753 | 0.9128 | 0.0394 | -- | 1.83 | 324,909.10 | -19.13 | -19.22 | -21.35 | -20.78 | -- | -- | -485.70 | -370.14 | -- | -- | 0.3172 | -- | -54.78 | 7.25 | 36.57 | -- | -13.35 | -- |
| Nfl Biosciences SAS | 0.00 | -3.48m | 20.67m | 3.00 | -- | 5.25 | -- | -- | -0.5396 | -0.5396 | 0.00 | 0.4097 | 0.00 | -- | -- | 0.00 | -80.79 | -- | -125.59 | -- | -- | -- | -- | -- | -- | -- | 0.0228 | -- | -- | -- | -149.78 | -- | -- | -- |
| Oncodesign Precision Medicine Opm SA | 1.07m | -8.09m | 23.65m | 22.00 | -- | 5.86 | -- | 22.06 | -0.4863 | -0.4863 | 0.0645 | 0.2219 | 0.0613 | -- | 1.39 | 48,735.00 | -46.23 | -- | -63.87 | -- | 130.48 | -- | -754.61 | -- | -- | -- | 0.7052 | -- | -86.57 | -- | -3,399.73 | -- | -- | -- |
| Advicenne SA | 2.37m | -10.39m | 23.83m | 25.00 | -- | -- | -- | 10.07 | -1.03 | -1.03 | 0.2342 | -1.40 | 0.1938 | 6.10 | 1.94 | 94,680.00 | -85.09 | -46.00 | -178.65 | -61.82 | -204.18 | -441.10 | -438.99 | -597.56 | 0.8356 | -6.22 | 4.33 | -- | -12.32 | 33.26 | 7.70 | -- | 26.86 | -- |
| Predilife SA | 317.79k | -4.22m | 26.41m | 19.00 | -- | -- | -- | 83.12 | -1.14 | -1.14 | 0.0858 | -1.06 | 0.0695 | -- | 2.05 | 17,030.55 | -92.43 | -89.36 | -129.39 | -123.81 | 97.25 | 83.94 | -1,329.21 | -1,901.22 | -- | -6.23 | 2.20 | -- | 10.11 | 79.85 | -15.58 | -- | -18.51 | -- |
| Poxel SA | 1.55m | -44.24m | 31.07m | 30.00 | -- | -- | -- | 20.10 | -1.44 | -1.44 | 0.0507 | -1.22 | 0.0597 | -- | 5.42 | 30,920.00 | -170.71 | -31.97 | -432.50 | -55.94 | 0.1294 | -- | -2,861.58 | -101.47 | -- | -4.08 | 11.28 | -- | -94.97 | -33.77 | -32.13 | -- | -8.49 | -- |
| Fermentalg SA | 4.06m | -14.15m | 32.54m | 62.00 | -- | 0.9979 | -- | 8.02 | -0.3176 | -0.3176 | 0.0917 | 0.6033 | 0.0753 | 0.533 | 3.35 | 65,451.61 | -24.63 | -21.94 | -26.79 | -24.71 | 13.21 | 14.73 | -327.08 | -248.95 | 3.53 | -60.94 | 0.3323 | -- | -46.94 | 75.18 | -43.29 | -- | -10.93 | -- |
| Global Bioenergies SA | 3.25m | -8.66m | 32.94m | 46.00 | -- | 3.16 | -- | 10.14 | -0.4797 | -0.4797 | 0.1802 | 0.5743 | 0.1632 | 5.21 | 65.62 | 70,638.05 | -43.47 | -43.66 | -64.54 | -82.47 | -153.20 | -948.35 | -266.41 | -1,331.36 | 3.54 | -- | 0.2626 | -- | 365.83 | 36.25 | 27.78 | -- | -19.49 | -- |
| Abionyx Pharma SA | 4.64m | -3.52m | 37.91m | 61.00 | -- | 4.75 | -- | 8.17 | -0.121 | -0.121 | 0.1581 | 0.246 | 0.3027 | 21.86 | 4.20 | 76,694.22 | -22.95 | -18.82 | -32.52 | -28.87 | 13.32 | 14.32 | -75.82 | -128.54 | 1.70 | -- | 0.2997 | -- | -11.65 | 92.84 | 16.36 | -- | 41.40 | -- |
| genOway SA | 18.63m | 1.59m | 39.41m | 124.00 | 23.43 | 2.31 | 9.83 | 2.12 | 0.1814 | 0.1814 | 2.12 | 1.84 | 0.5813 | 0.3881 | 2.50 | 142,180.80 | 4.98 | -0.5615 | 6.72 | -0.8058 | 97.61 | 93.72 | 8.56 | -1.12 | 2.10 | 17.42 | 0.3344 | -- | 21.64 | 11.57 | 341.09 | -16.63 | -18.02 | -- |
Data as of May 16 2024. Currency figures normalised to Predilife SA's reporting currency: Euro EUR
